CANF · Forms 3, 4, 5
Insider trades at Can-Fite BioPharma Ltd.
No open-market insider buys or sells at Can-Fite BioPharma Ltd. in the last 90 days; 9 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Can-Fite BioPharma Ltd. (CANF) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Can-Fite BioPharma Ltd. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Motti Farbstein | CEO, CFO and COO | Options or other derivatives | Form 4 | ||||
| Pnina Fishman | Chief Scientific Officer | Options or other derivatives | Form 4 | ||||
| Ilan Tamir | Director | Became an insider (Form 3) | Form 3 | ||||
| Guy Regev | Director | Became an insider (Form 3) | Form 3 | ||||
| Yoseph Bornstein | Director | Became an insider (Form 3) | Form 3 | ||||
| Abraham Sartani | Director | Became an insider (Form 3) | Form 3 | ||||
| Sari Fishman | VP Business Development | Became an insider (Form 3) | Form 3 | ||||
| Pnina Fishman | Chief Scientific Officer | Became an insider (Form 3) | Form 3 | ||||
| Motti Farbstein | CEO, CFO and COO | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.